These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35973341)

  • 1. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
    Khair S; Eastwood CA; Lu M; Jackson J
    Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
    Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
    Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island.
    Zang X; Bessey SE; Krieger MS; Hallowell BD; Koziol JA; Nolen S; Behrends CN; Murphy SM; Walley AY; Linas BP; Schackman BR; Marshall BDL
    JAMA Netw Open; 2022 Nov; 5(11):e2241174. PubMed ID: 36350649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
    Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
    J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
    O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
    Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Emergency Department, Hospital Discharge, and Death Data Be Used to Monitor Burden of Drug Overdose in Rhode Island?
    Jiang Y; McDonald JV; Koziol J; McCormick M; Viner-Brown S; Alexander-Scott N
    J Public Health Manag Pract; 2017; 23(5):499-506. PubMed ID: 28009694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.
    Irwin A; Jozaghi E; Weir BW; Allen ST; Lindsay A; Sherman SG
    Harm Reduct J; 2017 May; 14(1):29. PubMed ID: 28532488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths.
    Tse WC; Scott N; Dietze P; Nielsen S
    J Subst Abuse Treat; 2022 Dec; 143():108871. PubMed ID: 36182753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Timely Overdose Data to Address a Spike in Nonfatal Overdoses and Inform a Coordinated Community-Level Response in Rhode Island, 2019.
    Lasher L; Hallowell BD; Chambers LC; Koziol J; McDonald J; Elmaleh R; Karim S; Viner-Brown S
    Public Health Rep; 2021; 136(1_suppl):24S-30S. PubMed ID: 34726976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs.
    Adams JW; Savinkina A; Fox A; Behrends CN; Madushani RWMA; Wang J; Chatterjee A; Walley AY; Barocas JA; Linas BP
    Addiction; 2022 Oct; 117(10):2635-2648. PubMed ID: 35315148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior Emergency Medical Services Utilization Among People Who Had an Accidental Opioid-Involved Fatal Drug Overdose-Rhode Island, 2018-2020.
    Duan K; Chambers LC; Basta M; Scagos RP; Roberts-Santana C; Hallowell BD
    Public Health Rep; 2024; 139(1):48-53. PubMed ID: 36891978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study.
    Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S
    Int J Drug Policy; 2022 Dec; 110():103894. PubMed ID: 36308892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada.
    Scheim AI; Bouck Z; Tookey P; Hopkins S; Sniderman R; McLean E; Garber G; Baral S; Rourke SB; Werb D
    Int J Drug Policy; 2021 Jan; 87():102993. PubMed ID: 33160158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the Accuracy of Existing Overdose Surveillance Systems.
    Griffith J; Chambers LC; Hallowell BD; Gaipo A; Mailloux C; Baird J; Beaudoin FL; Samuels EA
    JAMA Netw Open; 2023 Jun; 6(6):e2320789. PubMed ID: 37378980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticipated use of a supervised drug consumption site among syringe services program clients in King County, Washington: Assessing the role of opioid overdose and injection behavior.
    Klein KS; Glick SN; Mauro PM
    Drug Alcohol Depend; 2020 Aug; 213():108121. PubMed ID: 32585421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.